The Center for Cancer and Blood Disorders

included 24 patients presented with 25 breast cancers. These patients received neoadjuvant chemotherapy in the form of 3 cycles of FAC regimen (5-flourouracil 500 mg/ m2 I.V. day 1, adriamycin 50 mg/ m2 I.V. day 1, & cyclophosphamide 500mg/ m2 I.V. day 1) with 21 days interval between each two successive cycles. 2- TAC Group: ................
................